FilingReader Intelligence
Hansoh Pharma reports 14% revenue growth in H1
August 18, 2025 at 05:00 PM UTC•By FilingReader AI
Hansoh Pharmaceutical Group reported revenue of RMB7.43bn for the first six months of 2025, up 14.3% year-over-year, with profit rising 15.0% to RMB3.13bn.
Innovative drugs and collaborative products accounted for 82.7% of total revenue. The company declared an interim dividend of HK$23.16 cents per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HKEX:3692•Hong Kong Exchange
News Alerts
Get instant email alerts when Hansoh Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime